Back to Tom Steyer
Tom Steyer → ROIV via FARALLON CAPITAL MANAGEMENT, L.L.C.
Tom Steyer ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
15
Latest value
$506.4M
Q2 2026
Peak value
$506.4M
First seen
Q2 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $506.4M | 14.31M | — | — |
| Q1 2026 | $268M | 9.68M | — | — |
| Q4 2025 | $803K | 37.0K | — | — |
| Q3 2025 | $560K | 37.0K | — | — |
| Q3 2025 | $560K | 37.0K | — | — |
| Q2 2025 | $417K | 37.0K | — | — |
| Q1 2025 | $373K | 37.0K | — | — |
| Q4 2024 | $438K | 37.0K | — | — |
| Q3 2024 | $427K | 37.0K | — | — |
| Q2 2024 | $7.1M | 673.0K | — | — |
| Q1 2024 | $9.5M | 898.6K | — | — |
| Q1 2024 | $9.5M | 898.6K | — | — |
| Q4 2023 | $82.4M | 7.34M | — | — |
| Q3 2023 | $45M | 3.85M | — | — |
| Q2 2023 | $23.7M | 2.35M | — | — |